ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665534 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665534; 2) Community: the network communities that were significantly associated with the response to NSC 665534; 3) Molecule: the relationships between components within communities and NSC 665534; 4) MDR: the compounds that were significantly associated with the NSC 665534.

NSC Compound Enrichment Correlation
NSC 116878 Cardiac glycoside 0.0376362543535812 0.23424683
NSC 138333 Null 0.0376362543535812 0.23382862
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0376362543535812 0.33500639
NSC 294734 7-Oxabicyclo[4.1.0]hept-3-ene-2,5-dione, 3-hydroxy-4-methyl-, (1R-cis)- 0.0376362543535812 0.24996277
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0376362543535812 0.42104462
NSC 373980 Null 0.0376362543535812 0.40954032
NSC 380721 Eremantholide B 0.0376362543535812 0.26667594
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0376362543535812 0.47808505
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0376362543535812 0.38946996
NSC 641054 Null 0.0376362543535812 0.24791894
Total:104  Current:76    [First] [Prev] [Next] [Last]